Inflammation, metaflammation and immunometabolic disorders
The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
Proper regulation and management of energy, substrate diversity and quantity, as well as macromolecular synthesis and breakdown processes, are fundamental to cellular and organismal survival and are paramount to health. Cellular and multicellular organization are defended by the immune response, a robust and critical system through which self is distinguished from non-self, pathogenic signals are recognized and eliminated, and tissue homeostasis is safeguarded. Many layers of evolutionarily conserved interactions occur between immune response and metabolism. Proper maintenance of this delicate balance is crucial for health and has important implications for many pathological states such as obesity, diabetes, and other chronic non-communicable diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypertrophic visceral adipose tissue is a primary driver of chronic, low-grade meta-inflammation, characterized by an accelerated secretion of pro-inflammatory cytokines (such as TNF-alpha and IL-6) and a concomitant reduction in protective adiponectin [9,11,12].”
From Trimester-Specific Bioelectrical Impedance Reference Curves in Physiological Pregnancy: Mapping Maternal Body Composition and Hydration Trajectories (2026) · cites this paper as [9]
In the citing paper
“Excess visceral adiposity does not merely represent a passive energy reserve; rather, it acts as an active immunometabolic organ [8-10].”
From Trimester-Specific Bioelectrical Impedance Reference Curves in Physiological Pregnancy: Mapping Maternal Body Composition and Hydration Trajectories (2026) · cites this paper as [9]
In the citing paper
“Inflammageing is now being recognized as a hallmark of ageing and a key driver of disease (FIG. 3Aa), including ageing-associated diseases, and has been described as a prominent risk factor for morbidity and death95–97.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
In the citing paper
“Chronic inflammation has profound effects on systemic metabolism, via a complicated crosstalk between immune cells and metabolic cells, such as hepatocytes and adipocytes, influencing metabolic processes such as glucose and lipid uptake, and insulin sensitivity96.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
In the citing paper
“For example, in obese tissues such as the visceral fat, peripheral monocytes are recruited by stressed adipocytes, leading to a progressive infiltration of proinflammatory M1-like macrophages and the displacement of the resident, anti-inflammatory M2 macrophages96.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Collino, M., Benetti, E., Rogazzo, M., Chiazza, F., Mastrocola, R., Nigro, D., Cutrìn, J. C., Aragno, M., Fantozzi, R., Minetto, M. A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12888 · Cited by 25
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Cited by
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
“In metabolically highly active organs such as the liver or adipose tissue, the crosstalk between immune cells and parenchymal cells plays a critical role in the pathogenesis of metabolic diseases.(178) Growing evidence shows that gut microbiome-derived metabolites can reach systemic circulation through the gut barrier…”
BackgroundInflammaging: a new immune–metabolic viewpoint for age-related diseases
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0059-4 · Cited by 3,586
Adipose tissue inflammation and metabolic dysfunction in obesity
Kawai, T., Autieri, M. V., & Scalia, R. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2020 · Cited by 1,947
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787
“A recent meta-analysis of studies with anti-TNF agents supports an overall protective effect of anti-TNF therapies on lifetime risk of diabetes as well as insulin sensitivity and obesity.(74) A recent large proof of concept trial of anti-inflammatory therapy in patients after myocardial infarction (A Randomized, Doubl…”
BackgroundResultInfluentialNAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
The Sleep-Immune Crosstalk in Health and Disease
Besedovsky, L., Lange, T., & Haack, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00010.2018 · Cited by 1,479
“(109, 244, 336, 485, 572), as well as immunodeficiency due to impaired DC, T, and B cell functions (80, 199, 422), which in turn can promote failure of tumor and pathogen defense (123, 426) (reviewed in Ref.”
BackgroundLipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner
Jaitin, D. A., Adlung, L., Thaiss, C. A., Weiner, A., Li, B., Descamps, H., Lundgren, P., Bleriot, C., Liu, Z., Deczkowska, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.054 · Cited by 1,377
“First, macrophages are critically involved in the progression of obesity and its metabolic complications (Hotamisligil, 2017).”
BackgroundMetabolic Instruction of Immunity
Buck, M. D., Sowell, R. T., Kaech, S. M., & Pearce, E. L. (2017) · Cell · doi:10.1016/j.cell.2017.04.004 · Cited by 1,214
“…inflammation is a well-established major risk factor for a plethora of diseases including heart disease, diabetes, metabolic syndromes, and cancer (Hotamisligil, 2017; Park et al., 2010), but our understanding of how inflammation contributes to the pathogenesis of these complex diseases is murky.”
NLRP3 inflammasome in cancer and metabolic diseases
Sharma, B. R., & Kanneganti, T.-D. (2021) · Nature Immunology · doi:10.1038/s41590-021-00886-5 · Cited by 1,097
The intestinal microbiota fuelling metabolic inflammation
Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0198-4 · Cited by 1,089
Metabolic Inflammation and Insulin Resistance in Obesity
Wu, H., & Ballantyne, C. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315896 · Cited by 1,059
“DOI: 10.1161/CIRCRESAHA.119.315896 May 22, 2020 1559 Anti-Inflammatory Thrombosis Outcomes Study) did not show long-term benefits in reducing HbA1c and reductions in incident T2DM.186 The potential of other therapies targeting the NLRP3 inflammasome pathway in treating T2DM remains to be assessed.”
BackgroundInfluentialMASLD: a systemic metabolic disorder with cardiovascular and malignant complications
Targher, G., Byrne, C. D., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2023-330595 · Cited by 897
“55 A very high rate of MASLD is observed in obese individuals, further strengthening the pathophysiological link between obesity and MASLD.”
BackgroundExtracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandão, B. B., & Kahn, C. R. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.011 · Cited by 961
“Low-grade inflammation in adipose tissue and liver is a common feature of obesity and metabolic syndrome (Franceschi et al., 2018; Hotamisligil, 2017; Mori et al., 2010; Odegaard and Chawla, 2013).”
BackgroundHyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., et al. (2018) · Science · doi:10.1126/science.aar3318 · Cited by 942
Farge, T., Saland, E., de Toni, F., Aroua, N., Hosseini, M., Perry, R., Bosc, C., Sugita, M., Stuani, L., Fraisse, M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0441 · Cited by 912
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
“JOURNAL OF HEPATOLOGY morpho-functional changes, occurring in a variety of organ systems that are potentially involved in the development of T2DM.”
BackgroundInfluentialMetformin: update on mechanisms of action and repurposing potential
Foretz, M., Guigas, B., & Viollet, B. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00833-4 · Cited by 699
Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids
Rogero, M., & Calder, P. (2018) · Nutrients · doi:10.3390/nu10040432 · Cited by 706
“This process allows for the continuity of the inflammatory reaction, which is associated with conditions, such as atherogenesis and insulin-action resistance [52,53].”
BackgroundThe spectrum of inflammatory responses
Medzhitov, R. (2021) · Science · doi:10.1126/science.abi5200 · Cited by 718
The aetiology and molecular landscape of insulin resistance
James, D. E., Stöckli, J., & Birnbaum, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00390-6 · Cited by 690
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571731 · Cited by 673
“Low grade chronic inflammation in obesity and T2D has been studied for more than 25 years (60), with several pathways to a large extend disentangled (197).”
BackgroundUnderstanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Foretz, M., Guigas, B., & Viollet, B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0242-2 · Cited by 686
Skeletal muscle: A review of molecular structure and function, in health and disease
Mukund, K., & Subramaniam, S. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1462 · Cited by 664
Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence
Kerr, J., Anderson, C., & Lippman, S. M. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30411-4 · Cited by 677
The endocrine function of adipose tissues in health and cardiometabolic disease
Scheja, L., & Heeren, J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0230-6 · Cited by 663
The gut microbiome and metabolic syndrome
Dabke, K., Hendrick, G., & Devkota, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129194 · Cited by 654
“This proximity establishes constant communication between metabolism and immune responses (75).”
BackgroundThe role of interleukin-1 in general pathology
Kaneko, N., Kurata, M., Yamamoto, T., Morikawa, S., & Masumoto, J. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0101-5 · Cited by 617
“In addition to several forms of inflammation including classical inflammation, homeostatic inflammation, a distinct nomenclature for low-grade inflammation, such as para-inflammation (an adaptive response against stress or malfunction) and meta-inflammation (metabolically triggered inflammation), has been proposed [17…”
BackgroundAdipokine dysregulation and adipose tissue inflammation in human obesity
Unamuno, X., Gómez‐Ambrosi, J., Rodríguez, A., Becerril, S., Frühbeck, G., & Catalán, V. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12997 · Cited by 610
Targher, G., Tilg, H., & Byrne, C. D. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00020-0 · Cited by 586
The pathogenesis of psoriatic arthritis
Veale, D. J., & Fearon, U. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30830-4 · Cited by 576
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells
Ang, Q. Y., Alexander, M., Newman, J. C., Tian, Y., Cai, J., Upadhyay, V., Turnbaugh, J. A., Verdin, E., Hall, K. D., Leibel, R. L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.027 · Cited by 569
Ballestri, S., Nascimbeni, F., Baldelli, E., Marrazzo, A., Romagnoli, D., & Lonardo, A. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0556-1 · Cited by 545
“Obesity, however, will typically exhibit changes in the innate and adaptive immune mechanisms [187].”
BackgroundEmerging Targets in Type 2 Diabetes and Diabetic Complications
Demir, S., Nawroth, P. P., Herzig, S., & Ekim Üstünel, B. (2021) · Advanced Science · doi:10.1002/advs.202100275 · Cited by 525
COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation
Zabetakis, I., Lordan, R., Norton, C., & Tsoupras, A. (2020) · Nutrients · doi:10.3390/nu12051466 · Cited by 532
“Chronic and unresolved inflammation is implicated in the onset, progression, and development of NCDs [87,88].”
BackgroundChilds, C. E., Calder, P. C., & Miles, E. A. (2019) · Nutrients · doi:10.3390/nu11081933 · Cited by 532
“This metabolism‐induced inflammation associated with obesity is 201 termed metaflammation, and the Western diet is a known risk factor[31,32].”
BackgroundEffect of High-Fat Diets on Oxidative Stress, Cellular Inflammatory Response and Cognitive Function
Tan, B. L., & Norhaizan, M. E. (2019) · Nutrients · doi:10.3390/nu11112579 · Cited by 511
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Tilg, H., Adolph, T. E., Dudek, M., & Knolle, P. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00501-9 · Cited by 507
Foundations of Immunometabolism and Implications for Metabolic Health and Disease
Hotamisligil, G. S. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.009 · Cited by 505
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
Dudek, M., Pfister, D., Donakonda, S., Filpe, P., Schneider, A., Laschinger, M., Hartmann, D., Hüser, N., Meiser, P., Bayerl, F., et al. (2021) · Nature · doi:10.1038/s41586-021-03233-8 · Cited by 518
Calder, P. C., Bosco, N., Bourdet-Sicard, R., Capuron, L., Delzenne, N., Doré, J., Franceschi, C., Lehtinen, M. J., Recker, T., Salvioli, S., et al. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.001 · Cited by 488
Targeting mitochondria-located circrna scar alleviates nash via reducing mros output
Zhao, Q., Liu, J., Deng, H., Ma, R., Liao, J.-Y., Liang, H., Hu, J., Li, J., Guo, Z., Cai, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.009 · Cited by 469
The quest to slow ageing through drug discovery
Partridge, L., Fuentealba, M., & Kennedy, B. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0067-7 · Cited by 468
Lancaster, G. I., Langley, K. G., Berglund, N. A., Kammoun, H. L., Reibe, S., Estevez, E., Weir, J., Mellett, N. A., Pernes, G., Conway, J. R. W., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.014 · Cited by 466
An Integrated View of Immunometabolism
Lee, Y. S., Wollam, J., & Olefsky, J. M. (2018) · Cell · doi:10.1016/j.cell.2017.12.025 · Cited by 436
“The role of subacute chronic inflammation, particularly in adipose tissue and liver, has been widely studied with respect to its role in systemic insulin resistance (Hotamisligil, 2017).”
BackgroundInfluentialAcute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
Montefusco, L., Ben Nasr, M., D’Addio, F., Loretelli, C., Rossi, A., Pastore, I., Daniele, G., Abdelsalam, A., Maestroni, A., Dell’Acqua, M., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00407-6 · Cited by 423
The Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells
Trivedi, P., Wang, S., & Friedman, S. L. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.026 · Cited by 427
“While emerging concepts of immunometabolism focus primarily on immune cells (Hotamisligil, 2017; Lee et al., 2018), HSCs also contribute significantly to convergent pathways of metainflammation and tissue injury, especially in alcoholic and non-alcoholic steatohepatitis (NASH) (Schwabe et al.”
BackgroundAging and Imaging Assessment of Body Composition: From Fat to Facts
Ponti, F., Santoro, A., Mercatelli, D., Gasperini, C., Conte, M., Martucci, M., Sangiorgi, L., Franceschi, C., & Bazzocchi, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00861 · Cited by 408
“Several studies showed that metaflammation may trigger obesity-induced insulin resistance, suggesting a causative role in T2DM itself (9) and in diabetes-induced complications (10).”
BackgroundMetabolic Messengers: tumour necrosis factor
Sethi, J. K., & Hotamisligil, G. S. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00470-z · Cited by 419
The NLRP3 inflammasome: Mechanism of action, role in disease and therapies
Wang, L., & Hauenstein, A. V. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100889 · Cited by 426
Hyaluronic acid and its biomedical applications: A review
Dovedytis, M., Liu, Z. J., & Bartlett, S. (2020) · Engineered Regeneration · doi:10.1016/j.engreg.2020.10.001 · Cited by 413
The spectrum of T cell metabolism in health and disease
Bantug, G. R., Galluzzi, L., Kroemer, G., & Hess, C. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.99 · Cited by 415
Targeting innate immune mediators in type 1 and type 2 diabetes
Donath, M. Y., Dinarello, C. A., & Mandrup-Poulsen, T. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0213-9 · Cited by 416
Inflammation and post‐traumatic stress disorder
Hori, H., & Kim, Y. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12820 · Cited by 407
“Of note, it is well recognized that obesity induces inflammation, leading to insulin resistance.(81) Findings from this line of research suggest that the increased proinflammatory activity in PTSD is due at least in part to metabolic abnormalities, such as diabetes and dyslipidemia, that are frequently seen in individ…”
BackgroundDietary modifications for enhanced cancer therapy
Kanarek, N., Petrova, B., & Sabatini, D. M. (2020) · Nature · doi:10.1038/s41586-020-2124-0 · Cited by 411
Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption
Kitaura, H., Marahleh, A., Ohori, F., Noguchi, T., Shen, W.-R., Qi, J., Nara, Y., Pramusita, A., Kinjo, R., & Mizoguchi, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145169 · Cited by 380
“TNF-α is central to the pathogenesis of disorders involving inflammation [96], such as obesity, which is characterized by chronic inflammation possibly via upregulation of TNF-α that activates the inflammatory cascade and affects various organ functions [36,97].”
BackgroundBrestoff, J. R., Wilen, C. B., Moley, J. R., Li, Y., Zou, W., Malvin, N. P., Rowen, M. N., Saunders, B. T., Ma, H., Mack, M. R., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.008 · Cited by 397
“In obesity, pro-inflammatory cytokines such as IFN-γ, LPS, and other stimuli promote the accumulation of M1-like macrophages in WAT (Brestoff and Artis, 2015; Caesar et al., 2012; Cani et al., 2007; Clemente-Postigo et al., 2019; Hotamisligil, 2017; Lee et al., 2018).”
BackgroundInfluentialThe interplay between immunosenescence and age-related diseases
Barbé-Tuana, F., Funchal, G., Schmitz, C. R. R., Maurmann, R. M., & Bauer, M. E. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00806-z · Cited by 384
Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer
Bishehsari, F., Voigt, R. M., & Keshavarzian, A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00427-4 · Cited by 375
Obese visceral fat tissue inflammation: from protective to detrimental?
Kolb, H. (2022) · BMC Medicine · doi:10.1186/s12916-022-02672-y · Cited by 353
“These include the local induction of insulin resistance in insulin-sensitive adipocytes resulting from engaging TNFα or other pro-inflammatory mediators including microRNAs and subsequent impairment of insulin signaling for lipolysis inhibition [26, 75].”
BackgroundAging, obesity, and inflammatory age-related diseases
Frasca, D., Blomberg, B. B., & Paganelli, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01745 · Cited by 371
“This occurs through both systemic inflammation and metaflammation (12), a process whereby excess nutrients promote chronic low-grade inflammation, and whose metabolic hallmarks are high levels of lipids, free fatty acids (FFAs), glucose, and reactive oxygen species (ROS).”
BackgroundTissue homeostasis and inflammation
Meizlish, M. L., Franklin, R. A., Zhou, X., & Medzhitov, R. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-061020-053734 · Cited by 364
Precision medicine in the era of artificial intelligence: implications in chronic disease management
Subramanian, M., Wojtusciszyn, A., Favre, L., Boughorbel, S., Shan, J., Letaief, K. B., Pitteloud, N., & Chouchane, L. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02658-5 · Cited by 362
Hildreth, A. D., Ma, F., Wong, Y. Y., Sun, R., Pellegrini, M., & O’Sullivan, T. E. (2021) · Nature Immunology · doi:10.1038/s41590-021-00922-4 · Cited by 359
Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity
Padoan, A., Plebani, M., & Basso, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030676 · Cited by 358
“Systemic diseases characterized by low-grade chronic inflammation, such as metaflammation in patients with the metabolic syndrome, and diabetes mellitus, also enhance the risk of cancer, particularly pancreatic cancer [20].”
BackgroundInfluentialNonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Llovet, J. M., Willoughby, C. E., Singal, A. G., Greten, T. F., Heikenwälder, M., El-Serag, H. B., Finn, R. S., & Friedman, S. L. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00754-7 · Cited by 354
Dietary Inflammatory Index and Non-Communicable Disease Risk: A Narrative Review
Phillips, C. M., Chen, L.-W., Heude, B., Bernard, J. Y., Harvey, N. C., Duijts, L., Mensink-Bout, S. M., Polanska, K., Mancano, G., Suderman, M., et al. (2019) · Nutrients · doi:10.3390/nu11081873 · Cited by 337
Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease
Liberale, L., Montecucco, F., Tardif, J.-C., Libby, P., & Camici, G. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz961 · Cited by 345
Więckowska-Gacek, A., Mietelska-Porowska, A., Wydrych, M., & Wojda, U. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101397 · Cited by 343
“This results in the secretion of pro-inflammatory agents from adipocytes and AT-resident immune cells such as tumor necrosis factor-α (TNFα), interleukin-6 (IL-6), interleukin-1β (IL-1β) nitric oxide synthase (iNOS), C-reactive protein (CRP), intercellular adhesion molecules (ICAM), and monocyte chemotactic protein-1…”
Chronic tissue inflammation and metabolic disease
Lee, Y. S., & Olefsky, J. (2021) · Genes & Development · doi:10.1101/gad.346312.120 · Cited by 335
Aging, melatonin, and the pro- and anti-inflammatory networks
Hardeland, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051223 · Cited by 337
“with low-grade inflammation, a phenomenon known under the term of metaflammation [110–112], which contributes to inflammaging [111,112].”
BackgroundModern-day environmental factors in the pathogenesis of osteoarthritis
Berenbaum, F., Wallace, I. J., Lieberman, D. E., & Felson, D. T. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0073-x · Cited by 323
Cardiovascular disease and cancer: shared risk factors and mechanisms
Wilcox, N. S., Amit, U., Reibel, J. B., Berlin, E., Howell, K., & Ky, B. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01017-x · Cited by 310
“Chronic systemic inflammation also increases the risk of hypertension, hyperlipidaemia and type 2 diabetes, which as detailed above, are established risk factors for CVD 143,144 .”
Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases
Furuhashi, M. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48710 · Cited by 319
The Homeostatic Force of Ghrelin
Yanagi, S., Sato, T., Kangawa, K., & Nakazato, M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.008 · Cited by 321
Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease
Tretina, K., Park, E.-S., Maminska, A., & MacMicking, J. D. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20182031 · Cited by 334
“, 2013), whereas intrinsic challenges arise from endogenous retroelements that promote oncogenesis or from metabolic disturbances that elicit inflammatory sequelae (Kassiotis and Stoye, 2016; O’Neill et al., 2016; Hotamisligil, 2017).”
BackgroundA guide to understanding endoplasmic reticulum stress in metabolic disorders
Lemmer, I. L., Willemsen, N., Hilal, N., & Bartelt, A. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101169 · Cited by 310
“What is the cause of inflammation in this metabolic context? This is a major topic of “immunometabolism” or “metaflammation” research [184], which unlike proposals by some in the field does not directly relate to the metabolism of immune cells during inflammation (which is simply metabolism, not immunometabolism) but…”
BackgroundKinlen, D., Cody, D., & O’Shea, D. (2018) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcx152 · Cited by 308
“This inflammatory state is present in organs such as the liver, brain, pancreas and adipose tissue and has been implicated in immuno-metabolic disease.(31) Immune cells are abundant in adipose tissue and obesityinduced activation of their inflammatory response causes changes in their number and activity.”
BackgroundChanges in Plasma Free Fatty Acids Associated with Type-2 Diabetes
I. S. Sobczak, A., A. Blindauer, C., & J. Stewart, A. (2019) · Nutrients · doi:10.3390/nu11092022 · Cited by 304
“Indeed, the term “metaflammation” has been coined to describe this state of chronic metabolic inflammation [123], which—besides having many other deleterious effects—is the major underlying cause of insulin resistance [113].”
BackgroundThe metabolic nature of inflammatory bowel diseases
Adolph, T. E., Meyer, M., Schwärzler, J., Mayr, L., Grabherr, F., & Tilg, H. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00658-y · Cited by 296
Ying, W., Gao, H., Dos Reis, F. C. G., Bandyopadhyay, G., Ofrecio, J. M., Luo, Z., Ji, Y., Jin, Z., Ly, C., & Olefsky, J. M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.019 · Cited by 301
“It has become clear that obesity-induced chronic, subacute tissue inflammation, particularly when it occurs in adipose tissue and liver, can cause insulin resistance (Hotamisligil, 2017; Saltiel and Olefsky, 2017).”
Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights
De Sá Coutinho, D., Pacheco, M. T., Frozza, R. L., & Bernardi, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061812 · Cited by 290
Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control
Próchnicki, T., & Latz, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.018 · Cited by 297
Brown adipose tissue whitening leads to brown adipocyte death and adipose tissue inflammation
Kotzbeck, P., Giordano, A., Mondini, E., Murano, I., Severi, I., Venema, W., Cecchini, M. P., Kershaw, E. E., Barbatelli, G., Haemmerle, G., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m079665 · Cited by 293
“ER stress and mitochondrial dysfunction have been implicated in causing adipocyte dysfunction and death and adipose tissue inflammation (10, 11, 33, 34).”
BackgroundTargeting PI3K/AKT signaling pathway in obesity
Savova, M. S., Mihaylova, L. V., Tews, D., Wabitsch, M., & Georgiev, M. I. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114244 · Cited by 277
Cell death and inflammation during obesity: “Know my methods, WAT(son)”
Hildebrandt, X., Ibrahim, M., & Peltzer, N. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-022-01062-4 · Cited by 277
“Obesity is a state of low-grade chronic inflammation that causes an array of different metabolic disorders, including insulin resistance (IR), Type 2 Diabetes, hypertension, cardiovascular disease, dyslipidemia and even cancer [2].”
Obesity, kidney dysfunction, and inflammation: interactions in hypertension
Hall, J. E., Mouton, A. J., da Silva, A. A., Omoto, A. C. M., Wang, Z., Li, X., & do Carmo, J. M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa336 · Cited by 265
“getic programming of immune responses are recognized as critical components of immunometabolism in adipose tissue and the liver.(113,114)”
BackgroundResultInfluentialRusso, S., Kwiatkowski, M., Govorukhina, N., Bischoff, R., & Melgert, B. N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746151 · Cited by 269
Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism
Lefere, S., & Tacke, F. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.02.004 · Cited by 278
“From this perspective, inflammatory mediators can be thought of as metabolic hormones that regulate insulin signalling.(14) In the last decades, macrophages have emerged as key regulators of inflammation-mediated insulin resistance.”
BackgroundPro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
Brennan, E., Kantharidis, P., Cooper, M. E., & Godson, C. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00454-y · Cited by 262
Low-Grade Inflammation and Ultra-Processed Foods Consumption: A Review
Tristan Asensi, M., Napoletano, A., Sofi, F., & Dinu, M. (2023) · Nutrients · doi:10.3390/nu15061546 · Cited by 257
“Although this condition recognized as low-grade inflammation has minimal or no clinical manifestations, the prolonged inflammatory response can cause consequences for tissue health, which can develop into tissue fibrosis and possible loss of function [13].”
BackgroundExploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination
Xia, Y., Wu, J., Wei, W., Du, Y., Wan, T., Ma, X., An, W., Guo, A., Miao, C., Yue, H., et al. (2018) · Nature Materials · doi:10.1038/nmat5057 · Cited by 268
Ying, W., Lee, Y. S., Dong, Y., Seidman, J. S., Yang, M., Isaac, R., Seo, J. B., Yang, B.-H., Wollam, J., Riopel, M., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.003 · Cited by 265
“This chronic metabolic inflammation (metaflammation) plays a critical role in causing insulin resistance (Gregor andHotamisligil, 2011; Hotamisligil, 2017; Lackey and Olefsky, 2016).”
BackgroundAdipocyte biology in breast cancer: From silent bystander to active facilitator
Choi, J., Cha, Y. J., & Koo, J. S. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.11.002 · Cited by 255
The PI3K/Akt Pathway in Meta-Inflammation
Acosta-Martinez, M., & Cabail, M. Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315330 · Cited by 244
“Recently, baricitinib, a selective JAK1/2 inhibitor used to treat rheumatoid arthritis [125], has been investigated for the treatment of T2D and its complications.”
BackgroundInfluentialGut microbiota and metabolic syndrome
Wang, P.-X., Deng, X.-R., Zhang, C.-H., & Yuan, H.-J. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000696 · Cited by 246
“Bacteria or their components, such as endotoxins, enter the circulation, causing low levels of inflammation, as a result of an imbalance in the gut microbiota and disruption of the gut barrier.([28,29])”
BackgroundInflammageing and metaflammation: The yin and yang of type 2 diabetes
Prattichizzo, F., De Nigris, V., Spiga, R., Mancuso, E., La Sala, L., Antonicelli, R., Testa, R., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.003 · Cited by 249
“The role of inflammation in induction of an alteration of metabolism is increasingly being accepted; a number of papers have provided considerable evidence (Hotamisligil, 2017).”
The role of T cells in age-related diseases
Carrasco, E., Gómez de las Heras, M. M., Gabandé-Rodríguez, E., Desdín-Micó, G., Aranda, J. F., & Mittelbrunn, M. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00557-4 · Cited by 239
Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation
Yan, H., Shao, D., Lao, Y., Li, M., Hu, H., & Leong, K. W. (2019) · Advanced Science · doi:10.1002/advs.201900605 · Cited by 240
Pillon, N. J., Loos, R. J. F., Marshall, S. M., & Zierath, J. R. (2021) · Cell · doi:10.1016/j.cell.2021.02.012 · Cited by 234
“…diseases and immunology emerged with the detection of macrophage infiltration in adipose tissue, followed by the discovery that lymphocytes, neutrophils, and other specific subtypes of immune cells accumulate not only in adipose tissue but also in skeletal muscle and liver (Hotamisligil, 2017).”
Metadata
- Authors
- Hotamisligil, G. S.
- Venue
- Nature
- Published
- 2017-02-09
- Volume
- 542
- Issue
- 7640
- Pages
- 177-185
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2587680743
- Cited by
- 2,570
- References
- 144
- Citations by year
- 2026: 501 · 2025: 322 · 2024: 264 · 2023: 253 · 2022: 252 · 2021: 296 · 2020: 283 · 2019: 217 · 2018: 125 · 2017: 57
- FWCI
- 24.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute for Health and Care Research
- Servier
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL125753)
- National Institute of Allergy and Infectious Diseases (R01AI116901)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK052539)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- inflammation, metabolic inflammation, immunometabolism, obesity, metabolic disorders, adipose tissue inflammation, non-communicable diseases, diabetes mellitus
- MeSH terms
- Animals, Clinical Trials as Topic, Hormones, Humans, Inflammation, Invertebrates, Metabolic Diseases, Obesity, Organelles, Signal Transduction, Cytokines, Evolution, Molecular, Genome-Wide Association Study, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.